Parkwalk Opportunities Fund has invested in Dynamic Vision Systems, a University of Manchester spinout developing smart contact lenses to address Presbyopia.

Information on the Target

Dynamic Vision Systems (DVS) is a spinout from the University of Manchester, established through collaborative research efforts with the University of Leeds. The company specializes in the development of smart contact lenses, particularly addressing the needs of individuals suffering from Presbyopia, a common age-related vision condition. DVS leverages advanced technology rooted in the expertise of professors in ophthalmology, liquid crystals, and innovative manufacturing techniques.

The company aims to revolutionize the approach to Presbyopia management, providing patients with a modern solution that surpasses conventional methods such as spectacles. By integrating cutting-edge technology into contact lenses, DVS hopes to enhance the quality of life for those impacted by this condition, which typically affects individuals from age 45 and sometimes even from age 35.

Industry Overview

The healthcare industry, particularly in the realm of vision correction, has seen significant advancements driven by technological innovation. Smart eyewear and contact lens technologies have garnered incr

View Source

Similar Deals

Cornerstone Gladys

2025

Seed Stage Home Healthcare Services United Kingdom
The Yield Lab NoBACZ Healthcare

2025

Seed Stage Bio Medical Devices United Kingdom
Sofinnova Partners Forth Therapeutics

2025

Seed Stage Bio Therapeutic Drugs United Kingdom
Lifted Ventures Anya

2025

Seed Stage Healthcare Facilities & Services (NEC) United Kingdom
redalpine, IQ Capital Partners, Seedcamp DaltonTx

2025

Seed Stage Proprietary & Advanced Pharmaceuticals United Kingdom
Access EIS MindSpire

2025

Seed Stage Alternative Medicine Facilities United Kingdom

Parkwalk Opportunities Fund

invested in

Dynamic Vision Systems

in 2023

in a Seed Stage deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert